HK1212625A1 - Anti-cxcl9, anti-cxcl10, anti-cxcl11, anti-cxcl13, anti-cxcr3 and anti-cxcr5 agents for inflammatory disorder -cxcl9-cxcl10-cxcl11-cxcl13-cxcr3 -cxcr5 - Google Patents

Anti-cxcl9, anti-cxcl10, anti-cxcl11, anti-cxcl13, anti-cxcr3 and anti-cxcr5 agents for inflammatory disorder -cxcl9-cxcl10-cxcl11-cxcl13-cxcr3 -cxcr5

Info

Publication number
HK1212625A1
HK1212625A1 HK16100660.1A HK16100660A HK1212625A1 HK 1212625 A1 HK1212625 A1 HK 1212625A1 HK 16100660 A HK16100660 A HK 16100660A HK 1212625 A1 HK1212625 A1 HK 1212625A1
Authority
HK
Hong Kong
Prior art keywords
cxcl11
cxcl13
cxcl9
cxcr5
cxcl10
Prior art date
Application number
HK16100660.1A
Other languages
Chinese (zh)
Inventor
‧利拉德 詹姆斯‧
Original Assignee
Jyant Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jyant Tech filed Critical Jyant Tech
Publication of HK1212625A1 publication Critical patent/HK1212625A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/715—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons
    • G01N2333/7158—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK16100660.1A 2012-06-27 2016-01-21 Anti-cxcl9, anti-cxcl10, anti-cxcl11, anti-cxcl13, anti-cxcr3 and anti-cxcr5 agents for inflammatory disorder -cxcl9-cxcl10-cxcl11-cxcl13-cxcr3 -cxcr5 HK1212625A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2012/044475 WO2014003744A1 (en) 2012-06-27 2012-06-27 Anti-cxcl9, anti-cxcl 10, anti-cxcl 11, anti-cxcl 13, anti-cxcr3 and anti-cxcr5 agents for inflammatory disorder

Publications (1)

Publication Number Publication Date
HK1212625A1 true HK1212625A1 (en) 2016-06-17

Family

ID=49783686

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16100660.1A HK1212625A1 (en) 2012-06-27 2016-01-21 Anti-cxcl9, anti-cxcl10, anti-cxcl11, anti-cxcl13, anti-cxcr3 and anti-cxcr5 agents for inflammatory disorder -cxcl9-cxcl10-cxcl11-cxcl13-cxcr3 -cxcr5

Country Status (3)

Country Link
CN (2) CN104870012A (en)
HK (1) HK1212625A1 (en)
WO (1) WO2014003744A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3046581B1 (en) 2013-09-16 2020-04-01 Children's Hospital Medical Center Compositions and methods for treatment of hsct-associated thrombotic microangiopathy
WO2016200627A1 (en) 2015-06-09 2016-12-15 Children's Hospital Medical Center Dosing algorithm for complement inhibitor
CN105505941A (en) * 2016-01-21 2016-04-20 中国人民解放军第四军医大学 Application of CXCL1 aptamer in preparation of reagent for detecting upper urinary tract urothelial carcinoma
CN106119348B (en) * 2016-06-27 2018-02-23 中南大学湘雅医院 A kind of myasthenia gravis detection kit and application for non-coding lnc CXCL1 and encoding gene cxcl1 being combined as detecting or diagnosing screening marker
CN106755356A (en) * 2016-12-05 2017-05-31 深圳市第二人民医院 For detecting arthritic mark, genetic chip and preparation method
CN107236023B (en) * 2017-05-12 2021-05-07 苏州创澜生物科技有限公司 Antigen composition for detecting tuberculosis infection and application thereof
CN111183360A (en) * 2017-07-19 2020-05-19 生物辐射欧洲有限公司 Biomarker combination for simultaneous assessment of non-alcoholic steatohepatitis and hepatic fibrosis status
CN107656067B (en) * 2017-09-18 2019-11-15 上海交通大学医学院附属上海儿童医学中心 A kind of detection method and its application for assessing SLE infant total disease mobility and kidney trouble mobility
WO2019108456A1 (en) * 2017-12-01 2019-06-06 Children's Hospital Medical Center Compositions for interferon blockade and methods of using same
WO2019133902A2 (en) 2017-12-28 2019-07-04 Astute Medical, Inc. Antibodies and assays for ccl14
WO2019217478A1 (en) * 2018-05-09 2019-11-14 Dermtech, Inc. Novel gene classifiers and uses thereof in autoimmune diseases
US20220120730A1 (en) * 2018-12-26 2022-04-21 Keio University Method for detecting sle
CN110251669B (en) * 2019-06-18 2023-05-19 中山大学附属第六医院 CXCL16 protein and application of monoclonal antibody thereof in preparation of medicines for preventing and/or treating intestinal injury diseases
CN110607362A (en) * 2019-10-12 2019-12-24 南通大学 Biological diagnosis marker for chronic pain diseases and application of CXCL10 in preparation of chronic pain medicines
WO2023213400A1 (en) * 2022-05-05 2023-11-09 Institute For Research In Biomedicine Antibodies against chemokines, method for identifying said antibodies and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003294290A1 (en) * 2002-11-15 2004-06-15 Morehouse School Of Medicine Anti-chemokine and associated receptor antibodies and uses for inhibition of inflammation.
AU2006305550B2 (en) * 2005-10-16 2013-05-02 Yeda Research & Development Co., Ltd Caspase-8 and skin diseases
US20090197286A1 (en) * 2006-02-06 2009-08-06 Rappaport Family Institute For Research In The Med Methods and Kit for Diagnosing T1DM
US20080199481A1 (en) * 2007-02-21 2008-08-21 Astrazeneca Ab Compounds
CN101679346B (en) * 2007-06-05 2014-10-22 塞诺菲-安万特股份有限公司 Substituted benzoylamino-indan-2-carboxylic acids and related compounds
PT2195023T (en) * 2007-08-29 2018-06-08 Sanofi Sa Humanized anti-cxcr5 antibodies, derivatives thereof and their uses
WO2009053493A1 (en) * 2007-10-26 2009-04-30 Galderma Research & Development Non-invasive method to perform skin inflammatory disease pharmaco-genomic studies and diagnosis method thereof
CN101833001B (en) * 2010-04-21 2013-08-28 广州瑞博奥生物科技有限公司 Protein chip kit for detecting inflammatory factors and preparation method thereof
WO2012024236A1 (en) * 2010-08-14 2012-02-23 Biogen Idec Ma Inc. LTβR BLOCKADE: METHODS FOR OPTIMIZING THERAPEUTIC RESPONSIVENESS OF PATIENTS

Also Published As

Publication number Publication date
CN104870012A (en) 2015-08-26
WO2014003744A1 (en) 2014-01-03
CN107478843A (en) 2017-12-15

Similar Documents

Publication Publication Date Title
HK1212625A1 (en) Anti-cxcl9, anti-cxcl10, anti-cxcl11, anti-cxcl13, anti-cxcr3 and anti-cxcr5 agents for inflammatory disorder -cxcl9-cxcl10-cxcl11-cxcl13-cxcr3 -cxcr5
HK1216009A1 (en) Prostacylin compositions and methods for using the same
DK2922554T3 (en) Terminalt modificeret rna
GB2508204B (en) Orthosis
EP2814472A4 (en) Dithioamine reducing agents
GB201304967D0 (en) .
IL237068A (en) 1,3-dioxanomorphides and 1,3-dioxanocodides
GB201204183D0 (en) .
ZA201403090B (en) Tropicalizing agent
EP2823830A4 (en) Mucosa-elevating agent
EP2894311A4 (en) Muffler
EP2884064A4 (en) Muffler
EP2837627A4 (en) Amidopyridine derivative, and use thereof
LT2858606T (en) Orthosis
PL2838352T3 (en) Feed-mixing wagon
ZA201409119B (en) Polymer-nsaid conjugate
EP2787050A4 (en) Lecithin-organogel-forming agent
TWI562734B (en) Sense-improving agent
EP2764870A4 (en) Sense-improving agent
GB201212457D0 (en) Smart-road-smart-smart-vehicle synergy
ZA201209168B (en) Descaling
GB201223358D0 (en) Combines
GB201223361D0 (en) Combines
AU344957S (en) Sideboard
GB201206393D0 (en) Use